$BHST Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.17 up 29.17% YoY
• Reported revenue of $8.84M up 3.78% YoY
• BioHarvest Sciences Inc. expects the CDMO business to generate $4-$5 million in revenue, while consolidated EBITDA losses are expected to be in the range of $3 million to $5 million.